256 related articles for article (PubMed ID: 27568180)
1. Chemotaxis-driven disease-site targeting of therapeutic adult stem cells in dystrophic epidermolysis bullosa.
Alexeev V; Donahue A; Uitto J; Igoucheva O
Stem Cell Res Ther; 2016 Aug; 7(1):124. PubMed ID: 27568180
[TBL] [Abstract][Full Text] [Related]
2. Pro-Inflammatory Chemokines and Cytokines Dominate the Blister Fluid Molecular Signature in Patients with Epidermolysis Bullosa and Affect Leukocyte and Stem Cell Migration.
Alexeev V; Salas-Alanis JC; Palisson F; Mukhtarzada L; Fortuna G; Uitto J; South A; Igoucheva O
J Invest Dermatol; 2017 Nov; 137(11):2298-2308. PubMed ID: 28736230
[TBL] [Abstract][Full Text] [Related]
3. Transplanted bone marrow-derived circulating PDGFRα+ cells restore type VII collagen in recessive dystrophic epidermolysis bullosa mouse skin graft.
Iinuma S; Aikawa E; Tamai K; Fujita R; Kikuchi Y; Chino T; Kikuta J; McGrath JA; Uitto J; Ishii M; Iizuka H; Kaneda Y
J Immunol; 2015 Feb; 194(4):1996-2003. PubMed ID: 25601922
[TBL] [Abstract][Full Text] [Related]
4. High Local Concentrations of Intradermal MSCs Restore Skin Integrity and Facilitate Wound Healing in Dystrophic Epidermolysis Bullosa.
Kühl T; Mezger M; Hausser I; Handgretinger R; Bruckner-Tuderman L; Nyström A
Mol Ther; 2015 Aug; 23(8):1368-1379. PubMed ID: 25858020
[TBL] [Abstract][Full Text] [Related]
5. Cell- and protein-based therapy approaches for epidermolysis bullosa.
Nyström A; Bruckner-Tuderman L; Kern JS
Methods Mol Biol; 2013; 961():425-40. PubMed ID: 23325662
[TBL] [Abstract][Full Text] [Related]
6. A hypomorphic mouse model of dystrophic epidermolysis bullosa reveals mechanisms of disease and response to fibroblast therapy.
Fritsch A; Loeckermann S; Kern JS; Braun A; Bösl MR; Bley TA; Schumann H; von Elverfeldt D; Paul D; Erlacher M; Berens von Rautenfeld D; Hausser I; Fässler R; Bruckner-Tuderman L
J Clin Invest; 2008 May; 118(5):1669-79. PubMed ID: 18382769
[TBL] [Abstract][Full Text] [Related]
7. Intravenously injected human fibroblasts home to skin wounds, deliver type VII collagen, and promote wound healing.
Woodley DT; Remington J; Huang Y; Hou Y; Li W; Keene DR; Chen M
Mol Ther; 2007 Mar; 15(3):628-35. PubMed ID: 17245357
[TBL] [Abstract][Full Text] [Related]
8. Rescue of the mucocutaneous manifestations by human cord blood derived nonhematopoietic stem cells in a mouse model of recessive dystrophic epidermolysis bullosa.
Liao Y; Ivanova L; Zhu H; Yahr A; Ayello J; van de Ven C; Rashad A; Uitto J; Christiano AM; Cairo MS
Stem Cells; 2015 Jun; 33(6):1807-17. PubMed ID: 25640200
[TBL] [Abstract][Full Text] [Related]
9. Efficacy of Human Placental-Derived Stem Cells in Collagen VII Knockout (Recessive Dystrophic Epidermolysis Bullosa) Animal Model.
Liao Y; Ivanova L; Sivalenka R; Plumer T; Zhu H; Zhang X; Christiano AM; McGrath JA; Gurney JP; Cairo MS
Stem Cells Transl Med; 2018 Jul; 7(7):530-542. PubMed ID: 29745997
[TBL] [Abstract][Full Text] [Related]
10. Gene-Modified Blister Fluid-Derived Mesenchymal Stromal Cells for Treating Recessive Dystrophic Epidermolysis Bullosa.
Kikuchi Y; Tamakoshi T; Ishida R; Kobayashi R; Mori S; Ishida-Yamamoto A; Fujimoto M; Kaneda Y; Tamai K
J Invest Dermatol; 2023 Dec; 143(12):2447-2455.e8. PubMed ID: 37302620
[TBL] [Abstract][Full Text] [Related]
11. Fibroblasts show more potential as target cells than keratinocytes in COL7A1 gene therapy of dystrophic epidermolysis bullosa.
Goto M; Sawamura D; Ito K; Abe M; Nishie W; Sakai K; Shibaki A; Akiyama M; Shimizu H
J Invest Dermatol; 2006 Apr; 126(4):766-72. PubMed ID: 16439972
[TBL] [Abstract][Full Text] [Related]
12. Intradermal injection of lentiviral vectors corrects regenerated human dystrophic epidermolysis bullosa skin tissue in vivo.
Woodley DT; Keene DR; Atha T; Huang Y; Ram R; Kasahara N; Chen M
Mol Ther; 2004 Aug; 10(2):318-26. PubMed ID: 15294178
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms of fibroblast cell therapy for dystrophic epidermolysis bullosa: high stability of collagen VII favors long-term skin integrity.
Kern JS; Loeckermann S; Fritsch A; Hausser I; Roth W; Magin TM; Mack C; Müller ML; Paul O; Ruther P; Bruckner-Tuderman L
Mol Ther; 2009 Sep; 17(9):1605-15. PubMed ID: 19568221
[TBL] [Abstract][Full Text] [Related]
14. Human cord blood-derived unrestricted somatic stem cells promote wound healing and have therapeutic potential for patients with recessive dystrophic epidermolysis bullosa.
Liao Y; Itoh M; Yang A; Zhu H; Roberts S; Highet AM; Latshaw S; Mitchell K; van de Ven C; Christiano A; Cairo MS
Cell Transplant; 2014 Mar; 23(3):303-17. PubMed ID: 23394106
[TBL] [Abstract][Full Text] [Related]
15. Restoration of type VII collagen expression and function in dystrophic epidermolysis bullosa.
Chen M; Kasahara N; Keene DR; Chan L; Hoeffler WK; Finlay D; Barcova M; Cannon PM; Mazurek C; Woodley DT
Nat Genet; 2002 Dec; 32(4):670-5. PubMed ID: 12426566
[TBL] [Abstract][Full Text] [Related]
16. Pathomechanisms of Altered Wound Healing in Recessive Dystrophic Epidermolysis Bullosa.
Cianfarani F; Zambruno G; Castiglia D; Odorisio T
Am J Pathol; 2017 Jul; 187(7):1445-1453. PubMed ID: 28460207
[TBL] [Abstract][Full Text] [Related]
17. Injection of recombinant human type VII collagen corrects the disease phenotype in a murine model of dystrophic epidermolysis bullosa.
Remington J; Wang X; Hou Y; Zhou H; Burnett J; Muirhead T; Uitto J; Keene DR; Woodley DT; Chen M
Mol Ther; 2009 Jan; 17(1):26-33. PubMed ID: 19018253
[TBL] [Abstract][Full Text] [Related]
18. The development of induced pluripotent stem cell-derived mesenchymal stem/stromal cells from normal human and RDEB epidermal keratinocytes.
Nakayama C; Fujita Y; Matsumura W; Ujiie I; Takashima S; Shinkuma S; Nomura T; Abe R; Shimizu H
J Dermatol Sci; 2018 Sep; 91(3):301-310. PubMed ID: 29933899
[TBL] [Abstract][Full Text] [Related]
19. Replenishment of type VII collagen and re-epithelialization of chronically ulcerated skin after intradermal administration of allogeneic mesenchymal stromal cells in two patients with recessive dystrophic epidermolysis bullosa.
Conget P; Rodriguez F; Kramer S; Allers C; Simon V; Palisson F; Gonzalez S; Yubero MJ
Cytotherapy; 2010 May; 12(3):429-31. PubMed ID: 20230217
[TBL] [Abstract][Full Text] [Related]
20. Congenital muscular dystrophy-associated inflammatory chemokines provide axes for effective recruitment of therapeutic adult stem cell into muscles.
Alexeev V; Olavarria J; Bonaldo P; Merlini L; Igoucheva O
Stem Cell Res Ther; 2020 Nov; 11(1):463. PubMed ID: 33138863
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
